4Vincent GM,Timothy KW,Leppert M,et al.The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome[J].N Engl J Med,1992,327(12):846-852.
5Jackman WM,Clark M,Friday KJ,et al.Ventricular tachyarrhythmias in the long QT syndromes[J].Med Clin North Am,1984,68(5):1079-1109.
6Jackman WM,Friday KJ,Anderson JL,et al.The long QT syndromes:a critical review,new clinical observations and a unifying hypothesis[J].Prog Cardiovasc Dis,1988,31(2):115-172.
7Roden DM.Cellular basis of drug-induced torsades de pointes[J].Br J Pharmacol,2008,154(7):1502-1507.
8Viskin S,Alla SR,Barron HV,et al.Mode of onset of torsade de pointes in congenital long QT syndrome[J].J Am Coll Cardiol,1996,28(5):1262-1268.
9Napolitano C,Priori SG,Schwartz PJ.Torsade de pointes.Mechanisms and management[J].Drugs,1994,47(1):51-65.
10Drew BJ,Ackerman MJ,Funk M,et al.Prevention of Torsade de Pointes in Hospital Settings.A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation[J].J Am Coll Cardiol,2010,55(9):934-947.
